Phoenix Medicaments Pvt Ltd
FDA import alert and refusal historyAhmedabad, IndiaFEI 3020740588
Recorded by FDA as PHOENIX MEDICAMENTS PVT LTD
As of October 25, 2026, Phoenix Medicaments Pvt Ltd is not on any FDA import alert in SupplierRadar's records; FDA refused 5 of its shipment lines between March 12, 2022 and August 1, 2025, most often for nutrition information missing from label (NUTRIT LBL).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Herbals & botanicals (not teas), n.e.c. · LIST INGRE
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Phoenix Medicaments Pvt Ltd
5 records, newest first. Each line links to the FDA page it came from.
2025
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.LIST INGREINCONSPICUNUTRIT LBLEntry AEK-3399230-4Source
2023
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNAPPROVEDEntry AEK-3410370-3Source
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.UNAPPROVEDEntry AEK-3362453-5Source
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.DIETARYLBLNCONTACTLABELINGNUTRIT LBLEntry AEK-2788472-3Source
2022
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTNUTRIT LBLUNAPPROVEDEntry AEK-0495682-5Source
Refusal charges, in plain English
- NUTRIT LBL3 refused lines
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
- UNAPPROVED3 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
- DIETARYLBL2 refused lines
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
- NCONTACT2 refused lines
No U.S. adverse event contact on supplement label
The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.
- INCONSPICU1 refused line
Required information not conspicuous
Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.
- LABELING1 refused line
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- LIST INGRE1 refused line
Ingredients not listed
The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).
Questions about Phoenix Medicaments Pvt Ltd
- Is Phoenix Medicaments Pvt Ltd on an FDA import alert?
- No listing for Phoenix Medicaments Pvt Ltd appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the India page.
- Has FDA refused shipments from Phoenix Medicaments Pvt Ltd?
- Yes. FDA refused 5 shipment lines from Phoenix Medicaments Pvt Ltd between March 12, 2022 and August 1, 2025. The most recent, on August 1, 2025, was herbals & botanicals (not teas), n.e.c., charged as LIST INGRE (ingredients not listed).
- Why did FDA refuse Phoenix Medicaments Pvt Ltd's shipments?
- The most frequent charges are NUTRIT LBL (nutrition information missing from label, 3 lines) and UNAPPROVED (unapproved new drug, 3 lines).
- What is Phoenix Medicaments Pvt Ltd's FEI number?
- Phoenix Medicaments Pvt Ltd's FDA Establishment Identifier (FEI) is 3020740588.
Buying from Phoenix Medicaments Pvt Ltd?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.